<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Palatino;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle20
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:95255397;
mso-list-type:hybrid;
mso-list-template-ids:1356626548 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:"Courier New";}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Wingdings;}
@list l1
{mso-list-id:743841075;
mso-list-template-ids:-1124300450;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l1:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2
{mso-list-id:1261597502;
mso-list-template-ids:-459789168;}
@list l2:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l2:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l2:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l2:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3
{mso-list-id:1462192006;
mso-list-template-ids:1308141434;}
@list l3:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l3:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l3:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l3:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l4
{mso-list-id:1483932236;
mso-list-template-ids:-1471799734;}
@list l4:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l4:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l4:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l4:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l4:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l4:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l4:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l4:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l4:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l5
{mso-list-id:1804810985;
mso-list-template-ids:1449582414;}
@list l5:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l5:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l5:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l5:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l5:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l5:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l5:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l5:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l5:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://www.klingfund.org/index.php__;!!PhOWcWs!mlB-pjRY5KPIiN9ZGJD16pPG-UdnzmEGxmC-5neMSoYxN89mf6sSTpVtPoN3u_0bLaMlVfAbz_Z-Pcup20Y$" target="_blank">Klingenstein-Simons Fellowship Awards in Neuroscience</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The Esther A. & Joseph Klingenstein Fund and the Simons Foundation are inviting applications for the Klingensten-Simons Fellowship Awards in Neuroscience, among the nation's oldest and
most illustrious fellowships for young investigators in neuroscience research. Through the program, fellowships of $225,000 over three years will be awarded to young investigators in support of basic or clinical research that leads to a better understanding
of neurological and psychiatric disorders. Areas of particular interest within the neurosciences include:<o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level1 lfo1"><span style="font-family:Palatino">Cellular and Molecular Neuroscience — Studies of the mechanisms of neuronal excitability and development, and of the genetic basis of behavior.<o:p></o:p></span></li><li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level1 lfo1"><span style="font-family:Palatino">Neural Systems — Studies of the integrative function of the nervous system.<o:p></o:p></span></li><li class="MsoListParagraph" style="margin-left:0in;mso-list:l0 level1 lfo1"><span style="font-family:Palatino">Translational Research — Studies designed to improve the prevention, diagnosis, treatment and our understanding of the causes of neurological and
psychiatric disorders.<o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Eligibility: The candidate must be an independent investigator at a university, medical center or research institute and be within 4 years of completing postdoctoral training and the start
of his/her tenure track or equivalent appointment (between July 1, 2016 and July 1, 2020).<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due February 15, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: February 3.</span></span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://nyscf.org/programs/extramural-grants/applicants/neuroscience-investigator-awards/__;!!PhOWcWs!mlB-pjRY5KPIiN9ZGJD16pPG-UdnzmEGxmC-5neMSoYxN89mf6sSTpVtPoN3u_0bLaMlVfAbz_Z-ZGXZrEc$" target="_blank">New York Stem Cell Foundation: Neuroscience Investigator Awards</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The mission of the New York Stem Cell Foundation is to accelerate cures for major disease through stem cell research. To that end, the foundation welcomes applications for its Neuroscience
Investigator Awards. Through the program, grants of $1.5 million over five years will be awarded to early-career investigators in support of bold, innovative research with the potential to transform the field of neuroscience. Applicants
<b>need not be working in areas related to stem cells or related areas</b>, and applications are encouraged in
<b>all areas of neuroscience</b>.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due February 19, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: February 6.</span></span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://www.livestrong.org/what-we-do/livestrong-solution-grants__;!!PhOWcWs!mlB-pjRY5KPIiN9ZGJD16pPG-UdnzmEGxmC-5neMSoYxN89mf6sSTpVtPoN3u_0bLaMlVfAbz_Z-4eAESyM$" target="_blank">Livestrong Solution Grants</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The LIVESTRONG Foundation’s LIVESTRONG Cancer Institute works to rethink the full range of cancer care, from prevention to diagnosis, treatment, survivorship, and end-of-life care — all
with a focus on the patient’s needs, values, and preferences. To advance this mission, the institute is inviting applications for its LIVESTRONG Solution Grants. Through the program, grants will be awarded in support of inventive, cutting-edge solutions to
overlooked problems in cancer. Funding priorities include post-treatment care; patient and caregiver education; comprehensive quality-of-life services; and streamlining systems and care. The foundation provides two levels of funding: grants of up to $20,000 through
its Acceleration Grants program, and grants of up to $100,000 through its Transformation Grants program.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Letters of intent due February 21, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: February 10.</span><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://www.astrazeneca-us.com/sustainability/healthcare-foundation/connections-for-cardiovascular-health.html*overview--0__;Iw!!PhOWcWs!mlB-pjRY5KPIiN9ZGJD16pPG-UdnzmEGxmC-5neMSoYxN89mf6sSTpVtPoN3u_0bLaMlVfAbz_Z-DDPb8zI$" target="_blank">AstraZeneca HealthCare Foundation:
Connections for Cardiovascular Health (CCH)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">CCH provides grants to U.S.-based nonprofit organizations engaged in charitable work at the community level in the United States in support of the program’s mission. Since its inception
in 2010, the Foundation’s CCH program has funded programs providing innovative, community-based approaches to improving cardiovascular health across the United States. CCH-funded programs use culturally appropriate approaches with measurable outcomes to address
specific unmet needs of communities across the country, especially underserved communities. Through the program, grants in the amount of $125,000 to $150,000 over one year will be awarded to eligible organizations that have never been funded by the foundation
through the CCH program.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due February 21, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: February 10.</span></span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://www.afar.org/research/funding/us-nam-catalyst-award/?utm_source=NASEM*News*and*Publications&utm_campaign=8ed0d14b05-EMAIL_CAMPAIGN_2020_01_13_10_20&utm_medium=email&utm_term=0_96101de015-8ed0d14b05-104314885&mc_cid=8ed0d14b05&mc_eid=ffb2694dd6__;Kysr!!PhOWcWs!mlB-pjRY5KPIiN9ZGJD16pPG-UdnzmEGxmC-5neMSoYxN89mf6sSTpVtPoN3u_0bLaMlVfAbz_Z-oaPkHeI$" target="_blank">U.S.
NAM Catalyst Award Competition: Healthy Aging</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">As part of the Healthy Longevity Global Competition, the U.S. National Academy of Medicine (“NAM”), with support from Johnson & Johnson Innovation, will issue up to 24 Catalyst Awards
per year between 2020 and 2022. Each Catalyst Award includes a $50,000 cash prize as well as travel costs to attend an annual Innovator Summit, beginning in summer 2021. The American Federation for Aging Research (AFAR) will collaborate with the NAM on the
application and scientific review process.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Catalyst Awards will reward bold, new, potentially transformative ideas to improve the physical, mental, or social well-being of people as they age, in a measurable and equitable way.
In particular, we seek ideas that aim to extend the human healthspan through innovative approaches. Applications may originate from any field or combination of fields (e.g., biology, chemistry, medicine, engineering, infrastructure, behavioral and social sciences,
technology, and policy). Ideas may focus on any stage of life, as long as they ultimately promote health as people age. Examples of topic areas include but are not limited to:<o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="mso-list:l3 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Biology of aging and molecular pathways<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l3 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Physical health (e.g., mobility and functionality)<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l3 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Built environment and urban planning<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l3 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Disease prevention, including biomarkers and indicators of disease<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l3 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Health care delivery<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l3 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Housing (e.g., smart-enabled homes, intergenerational housing models)<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l3 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Policy (e.g., economic, health, and science policy)<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l3 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Behavioral health (e.g., social connectedness, engagement, and well-being)<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l3 level1 lfo2"><span style="font-size:12.0pt;font-family:Palatino">Technology (e.g., artificial intelligence; robotics; medical, assistive, and information-technology)<o:p></o:p></span></li></ul>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due February 24, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: February 11.</span></span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://www.rwjf.org/en/library/funding-opportunities/2020/interdisciplinary-research-leaders.html__;!!PhOWcWs!mlB-pjRY5KPIiN9ZGJD16pPG-UdnzmEGxmC-5neMSoYxN89mf6sSTpVtPoN3u_0bLaMlVfAbz_Z-c4r2toY$" target="_blank">Robert Wood Johnson Foundation: Interdisciplinary Research
Leaders</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Interdisciplinary Research Leaders (IRL) is a three-year national leadership development program that aims to foster and support new interdisciplinary, action-oriented research collaborations
that will help build the evidence base for effective community interventions to improve health for all. The 2020 cohort will focus on either of these two themes: Community Environment and Health or Families and Child Health. We’ll support teams of mid-career
individuals who come from diverse disciplinary backgrounds or scientific perspectives. The community-engaged partner on the team may work in a variety of organizational settings and have relevant expertise in the proposed research project. For the 2020 cohort,
we will select up to 15 teams of three mid-career individuals each (two researchers and a community partner per team). The applicant organization will receive up to $350,000, including $25,000 per year per fellow, and a portion of the $350,000 to the team
toward research activities.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Those selected to participate in IRL can expect to:<o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="mso-list:l2 level1 lfo3"><span style="font-size:12.0pt;font-family:Palatino">Develop, execute, and disseminate a detailed proposal for the team’s specific research project;<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l2 level1 lfo3"><span style="font-size:12.0pt;font-family:Palatino">Participate in weekly online learning activities, networking, and occasional in-person meetings (2–3 times per year);<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l2 level1 lfo3"><span style="font-size:12.0pt;font-family:Palatino">Increase expertise in interdisciplinary research team-building and authentic community engagement;<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l2 level1 lfo3"><span style="font-size:12.0pt;font-family:Palatino">Enhance competencies in a variety of rigorous qualitative and quantitative research methodologies, and better interpret findings and leverage them for
action;<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l2 level1 lfo3"><span style="font-size:12.0pt;font-family:Palatino">Have an understanding of the constraints to action (e.g., structural racism in historical and contemporary contexts);<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l2 level1 lfo3"><span style="font-size:12.0pt;font-family:Palatino">Enhance skills to ensure ethical research and community standards remain a priority;<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l2 level1 lfo3"><span style="font-size:12.0pt;font-family:Palatino">Understand the policy process and how best to communicate research evidence to inform policy.<o:p></o:p></span></li></ul>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due March 11, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: February 27.</span></span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://www.rwjf.org/en/library/funding-opportunities/2020/clinical-scholars.html__;!!PhOWcWs!mlB-pjRY5KPIiN9ZGJD16pPG-UdnzmEGxmC-5neMSoYxN89mf6sSTpVtPoN3u_0bLaMlVfAbz_Z-Y1is6A4$" target="_blank">Robert Wood Johnson Foundation: Clinical Scholars</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Clinical Scholars is a three-year,
<i>team-based program </i>for a wide variety of health professionals in community, clinical, or academic settings. By the end of the program, fellows will have gained the skills they need to appraise, synthesize, use the best evidence to guide practice and
inform policy in addressing complex health problems in their teams, organizations, and communities. We are seeking up to 35 individuals (in teams of three to five) with the potential to become national change leaders in their focus areas and a demonstrated
long-term commitment to fostering and achieving health equity.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Those selected for this program will engage in:<o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="mso-list:l4 level1 lfo4"><span style="font-size:12.0pt;font-family:Palatino">Personal, in-depth leadership training in health equity and community engagement<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l4 level1 lfo4"><span style="font-size:12.0pt;font-family:Palatino">Collaborative work across disciplines and professions to tackle problems that emerge from complex systems in communities<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l4 level1 lfo4"><span style="font-size:12.0pt;font-family:Palatino">Robust and customizable distance-based learning (8–10 hours/month)<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l4 level1 lfo4"><span style="font-size:12.0pt;font-family:Palatino">Required in-person team meetings/activities
<a href="https://urldefense.com/v3/__http://clinicalscholarsnli.org/about/upcoming-dates/__;!!PhOWcWs!mlB-pjRY5KPIiN9ZGJD16pPG-UdnzmEGxmC-5neMSoYxN89mf6sSTpVtPoN3u_0bLaMlVfAbz_Z-OMDQvTw$" target="_blank">three times per year</a><o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l4 level1 lfo4"><span style="font-size:12.0pt;font-family:Palatino">Planning and implementation of your team’s “Wicked Problem Impact Project”<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l4 level1 lfo4"><span style="font-size:12.0pt;font-family:Palatino">Receipt of grant funds based on team size (from up to $315,000 for a three-person to $525,000 for a five-person team)<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l4 level1 lfo4"><span style="font-size:12.0pt;font-family:Palatino">Mentoring and networking across all Clinical Scholars cohorts, other RWJF leadership programs, and with experts nationwide.<o:p></o:p></span></li></ul>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Due March 11, 2020.
<span style="color:red">Med-RA deadline to receive draft documents: February 27.</span></span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino"><a href="https://urldefense.com/v3/__https://www.nsf.gov/pubs/2020/nsf20532/nsf20532.htm__;!!PhOWcWs!mlB-pjRY5KPIiN9ZGJD16pPG-UdnzmEGxmC-5neMSoYxN89mf6sSTpVtPoN3u_0bLaMlVfAbz_Z-uB0pNOQ$" target="_blank">NSF: Enabling Discovery through GEnomic Tools (EDGE)</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">A comprehensive understanding of the functional mechanisms that connect genotype-to-phenotypes is a grand challenge in biology. Support for research on diverse organisms is critical for
developing strong inferences about the rules governing the mechanisms that bidirectionally connect genomes and phenomes. The objective of the EDGE program is to provide support for genetic and/or genomic research and associated theory, approach, tool, and
infrastructure development that address the mechanistic basis of complex traits in diverse organisms within the context (environmental, developmental, social, and/or genomic) in which they function.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">The EDGE program will accept proposals to two submission tracks:<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">FUNCTIONAL GENOMIC TOOLS TRACK</span></b><span style="font-size:12.0pt;font-family:Palatino">: Proposals submitted to this track should propose to develop and provide proof-of-concept
tests of functional genomic tools and infrastructure to enable direct tests of hypotheses about gene function in diverse plants, animals, microbes, viruses or fungi for which such tools and infrastructure are presently unavailable.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Examples of relevant objectives for plants, animals, microbes, viruses or fungi for which such tools and infrastructure are presently unavailable include, but are not limited to:<o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="mso-list:l5 level1 lfo5"><span style="font-size:12.0pt;font-family:Palatino">Development of mutant libraries and/or high-quality reference genomes<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l5 level1 lfo5"><span style="font-size:12.0pt;font-family:Palatino">Expansion of the use of gene editing, knock-out, and overexpression approaches for manipulating individual genes or interrogating multiple genes simultaneously
in diverse organisms;<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l5 level1 lfo5"><span style="font-size:12.0pt;font-family:Palatino">Development of approaches to test gene function in a variety of targeted, single cells in organisms;<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l5 level1 lfo5"><span style="font-size:12.0pt;font-family:Palatino">Generalizable high throughput phenotyping methods;<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l5 level1 lfo5"><span style="font-size:12.0pt;font-family:Palatino">Innovative approaches for establishing function of single or networks of genes; and<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l5 level1 lfo5"><span style="font-size:12.0pt;font-family:Palatino">Development and testing of transformation approaches.<o:p></o:p></span></li></ul>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">COMPLEX MULTIGENIC TRAITS TRACK:</span></b><span style="font-size:12.0pt;font-family:Palatino"> Prior investments of the EDGE program have led to more wide-spread examination of genome(s)-to-phenome(s)
relationships in many emerging model plants, animals, microbes, viruses and fungi. However, in these systems functional genomics has largely been limited to identifying candidate genes followed by single gene manipulation. Although, single gene manipulation
allows interrogation of genes of large effect it does not significantly advance our understanding of complex multigenic organismal traits across a variety of contexts (i.e. environmental, developmental, social and/or genomic). The EDGE program recognizes that
many of the traits of interest to biologists are quantitative in nature and are controlled by many genes of small effect and that understanding complex traits requires systems-level analysis of the underlying gene regulatory networks that goes beyond linking
individual genes with said traits.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Submissions to this track may include but are not limited to:<o:p></o:p></span></p>
<ul style="margin-top:0in" type="disc">
<li class="MsoNormal" style="mso-list:l1 level1 lfo6"><span style="font-size:12.0pt;font-family:Palatino">Systems-level analysis of the gene regulatory networks underlying complex traits;<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l1 level1 lfo6"><span style="font-size:12.0pt;font-family:Palatino">Elucidation of the causal connections across levels of biological organization that underlie complex multigenic traits;<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l1 level1 lfo6"><span style="font-size:12.0pt;font-family:Palatino">New or innovative analytical approaches to linking genes and complex traits; and<o:p></o:p></span></li><li class="MsoNormal" style="mso-list:l1 level1 lfo6"><span style="font-size:12.0pt;font-family:Palatino">Multi-genome/epigenome interactions with the environment towards the goal of predicting complex organismal phenotypes across contexts.<o:p></o:p></span></li></ul>
<p class="MsoNormal"><span style="font-size:12.0pt;font-family:Palatino">Budget requests should be commensurate with the goals of the project. The EDGE program expects to make awards covering the full range of budget requests commensurate with the size and
scope of each project.<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino">Proposals accepted anytime.
<span style="color:red">Med-RA deadline to receive draft documents: 10 business days before submission to sponsor.<o:p></o:p></span></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:red"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt;font-family:Palatino;color:black">To search for additional funding opportunities, please visit </span></b><span style="font-size:12.0pt;font-family:Palatino;color:black"><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV6980C-DCl-AxzFLHMVYQ&e=" title="https://urldefense.proofpoint.com/v2/url?u=https-3A__fsucomgrants.wordpress.com_&d=DwMGaQ&c=HPMtquzZjKY31rtkyGRFnQ&r=EXkFPz4CfHp2YvDR6s1e2OHGNt7ixTIGEDylKw2SIo1FQ8O9soOgOzmn5ZTHU62o&m=-WQkPIXZLCgXlX-d14DY8B-SG-GvP9FZHr_Gv8sUuTQ&s=ErAzzubGxiJsWCKGnlFjfXV69"><b><span style="color:red">CoM’s
unofficial funding opportunities blog</span></b></a></span><b><span style="font-size:12.0pt;font-family:Palatino;color:red">.</span></b><span style="font-size:12.0pt;font-family:Palatino"><o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-family:Palatino"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:9.0pt;font-family:"Times New Roman",serif">You have received this email because you are subscribed to the College of Medicine Funding Opportunities Listserv. If you no longer wish to receive funding opportunity emails
and the monthly Med-RA Newsletter from the College of Medicine Funding Opportunities Listserv, please
</span><a href="http://med.fsu.edu/index.cfm?fuseaction=forms.displayForm&formID=4&usemenu=&useTemplate=column"><span style="font-size:9.0pt;font-family:"Times New Roman",serif">click here</span></a><span style="font-size:9.0pt;font-family:"Times New Roman",serif">
to unsubscribe. If you received this as a forwarded email and would like to subscribe to the Listserv,
</span><a href="https://med.fsu.edu/index.cfm?fuseaction=forms.displayForm&formID=3&usemenu=&useTemplate=column"><span style="font-size:9.0pt;font-family:"Times New Roman",serif">click here</span></a><span style="font-size:9.0pt;font-family:"Times New Roman",serif">.
Thank you.</span><span style="font-size:9.0pt;font-family:"Times New Roman",serif"><o:p></o:p></span></p>
<p class="MsoNormal"><b><o:p> </o:p></b></p>
<p class="MsoNormal"><span style="font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:Palatino"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:Palatino"><o:p> </o:p></span></p>
</div>
</body>
</html>